Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Glaucoma Surgery Market

ID: MRFR/MED/0834-HCR
80 Pages
Nidhi Mandole
Last Updated: May 15, 2026

Glaucoma Surgery Market Research Report Information By Target (Trabecular meshwork, Suprachoroidal space, Posterior Fusion), By Type of surgery (Angle closure glaucoma surgery, Aqueous shunt surgery, laser surgery, And Others), By End Users (Hospital, Ambulatory surgery centers, And Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Glaucoma Surgery Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Glaucoma Surgery Market, BY Surgery Type (USD Million)
      1. 4.1.1 Trabeculectomy
      2. 4.1.2 Tube Shunt Surgery
      3. 4.1.3 Laser Surgery
      4. 4.1.4 Minimally Invasive Glaucoma Surgery
      5. 4.1.5 Cyclophotocoagulation
    2. 4.2 Glaucoma Surgery Market, BY Indication (USD Million)
      1. 4.2.1 Primary Open-Angle Glaucoma
      2. 4.2.2 Angle-Closure Glaucoma
      3. 4.2.3 Normal Tension Glaucoma
      4. 4.2.4 Secondary Glaucoma
      5. 4.2.5 Pediatric Glaucoma
    3. 4.3 Glaucoma Surgery Market, BY Technology (USD Million)
      1. 4.3.1 Traditional Surgical Techniques
      2. 4.3.2 Laser Technology
      3. 4.3.3 Micro-Invasive Techniques
      4. 4.3.4 Robotic-Assisted Surgery
      5. 4.3.5 Endoscopic Techniques
    4. 4.4 Glaucoma Surgery Market, BY Region (USD Million)
      1. 4.4.1 North America
        1. 4.4.1.1 US
        2. 4.4.1.2 Canada
      2. 4.4.2 Europe
        1. 4.4.2.1 Germany
        2. 4.4.2.2 UK
        3. 4.4.2.3 France
        4. 4.4.2.4 Russia
        5. 4.4.2.5 Italy
        6. 4.4.2.6 Spain
        7. 4.4.2.7 Rest of Europe
      3. 4.4.3 APAC
        1. 4.4.3.1 China
        2. 4.4.3.2 India
        3. 4.4.3.3 Japan
        4. 4.4.3.4 South Korea
        5. 4.4.3.5 Malaysia
        6. 4.4.3.6 Thailand
        7. 4.4.3.7 Indonesia
        8. 4.4.3.8 Rest of APAC
      4. 4.4.4 South America
        1. 4.4.4.1 Brazil
        2. 4.4.4.2 Mexico
        3. 4.4.4.3 Argentina
        4. 4.4.4.4 Rest of South America
      5. 4.4.5 MEA
        1. 4.4.5.1 GCC Countries
        2. 4.4.5.2 South Africa
        3. 4.4.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Alcon (CH)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Johnson & Johnson (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Bausch + Lomb (CA)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Carl Zeiss (DE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Santen Pharmaceutical (JP)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Glaukos Corporation (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Merck & Co. (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Novartis (CH)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 AbbVie (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports

Glaucoma Surgery Market Segmentation

Glaucoma Surgery Market By Surgery Type (USD Million, 2025-2035)

  • Trabeculectomy
  • Tube Shunt Surgery
  • Laser Surgery
  • Minimally Invasive Glaucoma Surgery
  • Cyclophotocoagulation

Glaucoma Surgery Market By Indication (USD Million, 2025-2035)

  • Primary Open-Angle Glaucoma
  • Angle-Closure Glaucoma
  • Normal Tension Glaucoma
  • Secondary Glaucoma
  • Pediatric Glaucoma

Glaucoma Surgery Market By Technology (USD Million, 2025-2035)

  • Traditional Surgical Techniques
  • Laser Technology
  • Micro-Invasive Techniques
  • Robotic-Assisted Surgery
  • Endoscopic Techniques

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions